Prevention of early glomerulopathy with tolrestat in the streptozotocin-induced diabetic rat

Biochemistry and Cell Biology

Volumn 74, Issue 3, 1996, Pages 355-362

  Donnelly, Sandra M ^a   Zhou, Xiaopeng P ^b   Huang, Jannet T ^a   Whiteside, Catharine I ^b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Aldose reductase; Mesangium; Nephropathy; Renal hemodynamics; Renal morphometry

Indexed keywords

AMPHOLYTE; NAPHTHALENE DERIVATIVE; POLYMER; POLYOL; TOLRESTAT;

ANIMAL; ARTICLE; DIABETIC NEPHROPATHY; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GLOMERULUS; MALE; METABOLISM; PATHOLOGY; RAT; SCIATIC NERVE; SPRAGUE DAWLEY RAT;

AMPHOLYTE MIXTURES; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; KIDNEY GLOMERULUS; MALE; NAPHTHALENES; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE;

EID: 0030338728     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o96-038     Document Type: Article

References (38)

1. Bank, N., Mower, P., Aynedjian, H.S., Wilkes, B.M., and Silverman, S. 1989. Sorbinil prevents glomerular hyperperfusion in diabetic rats. Am. J. Physiol. 256: F1000-F1006.
2. Beyer-Mears, A. 1986. The polyol pathway, sorbinil, and renal dysfunction. Metabolism, 35(4): 46-54.
3. Bhatnagar, A., Liu, S., Das, B., Ansari, N.H., and Srivastava, S.K. 1990. Inhibition kinetics of human kidney aldose and aldehyde reductases by aldose reductase inhibitors. Biochem. Pharmacol. 39: 1115-1124.
4. Bricker, N.S., Morrin, P.A.F., and Kime, S.W. 1960. The pathologic physiology of chronic Bright's disease: an exposition of the "intact nephron hypothesis." Am. J. Med. 28: 77-98.
5. Brownlee, M. 1994. Glycation and diabetic complications. Diabetes, 43: 836-841.
6. Daniels, B.S., and Hostetter, T.H. 1989. Aldose reductase inhibition and glomerular abnormalities in diabetic rats. Diabetes, 38: 981-986.
7. Danne, T., Spiro, M.J., and Spiro, R.G. 1993. Effect of high glucose onype IV collagen production by cultured glomerular epithelial, endothelial, and mesangial cells. Diabetes, 42: 170-177.
8. deRubertis, F.R., and Craven, P.A. 1994. Activation of protein kinase C in glomerular cells in diabetes. Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes, 43: 1-8.
9. Diabetes Control and Complications Trial Research Group (DCCT). 1993. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl. J. Med. 329: 977-986.
10. Fujihara, C.K., Padilha, R.M., and Zatz, R. 1992. Glomerular abnormalities in long-term experimental diabetes. Role of hemodynamic and nonhemodynamic factors and effects of antihypertensive therapy. Diabetes, 41: 286-293.
11. Greene, D.A., and Lattimer, S.A. 1984. Action of sorbinil in diabetic peripheral nerve-relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity. Diabetes, 33: 712-716.
12. Greene, D.A., Lattimer, S.A., and Sima, A.A.F. 1987. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N. Engl. J. Med. 316: 599-606.
13. Goldfarb, S., Simmons, D.A., and Kern, E.F.O. 1986. Amelioration of glomerular hyperfiltration in acute experimental diabetes mellitus by dietary myo-inositol supplementation and aldose reductase inhibition. Trans. Assoc. Am. Physicians, 99: 67-72.
14. Guerrant, G.O., and Moss, C.W. 1984. Determination of monosaccharrides as aldononitrile o-melhyloxime, alditol and cyclitol acetate derivatives by gas chromatography. Anal. Chem. 56: 633.
15. Hostetter, T.H., Troy, J.L., and Brenner, B.M. 1981. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int. 29: 410-415.
16. Hurst, R.D., Whiteside, C.I., and Thompson, J.C. 1992. Diabetic rat glomerular mesangial cells display normal inositol triphosphate and calcium release. Am. J. Physiol. 263: F649-F655.
17. Kikkawa, R., Kitamura, E., Fujiwara, Y., Arimura, T., Haneda, M., and Shigela, V. 1986. Impaired contractile responsiveness of diabetic glomeruli to angiotensin II: a possible indication of mesangial dysfunction in diabetes mellitus. Biochem. Biophys. Res. Commun. 136: 1185-1190.
18. Kinoshita, J.H., Kador, P.F., Robinson, G., Datilis, M.B., Cobo, L.M., and Kupfer, C. 1984. Aldose reductase and complications of diabetes. Ann. Intern. Med. 101: 82-91.
19. Klahr, S., Schreiner, G., and Ichikawa, I. 1988. The progression of renal disease. N. Engl. J. Med. 318: 1657-1666.
20. Kriesberg, J.I. 1992. Hyperglycemia and microangiopathy. Direct regulation by glucose of microvascular cells. Lab. Invest. 67: 416.
21. Kriesberg, J.I., Venkatachalam, M.A., and Troyer, D.A. 1985. Contractile properties of cultured glomerular mesangial cells. Am. J. Physiol. 249: F457-F463.
22. Mauer, S.M., Steffes, M.W., Ellis, E.N., Sutherland, D.E.R, Brown, D.M., and Goetz, F.C. 1984. Structural-functional relationships in diabetic nephropathy. J. Clin. Invest. 74: 1143-1155.
23. Mauer, S.M., Steffes, M.W., Azar, S., and Brown, D.M. 1989. Effects of sorbinil on glomerular structure and function in long-term-diabetic rats. Diabetes, 38: 839-846.
24. McCaleb, M.L., McKean, M.L., Hohman, T.C., Laver, N., and Robison, Jr., W.G. 1991. Intervention with the aldose reductase inhibitor, tolrestat, in renal and retinal lesions of streptozotocin-diabetic rats. Diabetologia, 34: 695-701.
25. Narayanan, S. 1993. Aldose reductase and its inhibition in the control of diabetic complications. Ann. Clin. Lab. Sc. 23(2): 148-158.
26. O'Donnell, M.P., Kasiske, B.L., and Keane, W.F. 1988. Glomerular hemodynamic and structural alterations in experimental diabetes mellitus. FASEB J. 2: 2339-2347.
27. Osterby, R., Parving, H.H., Nyberg, G., Jorgensen, H., Lokkegaard, H., and Svalander, C. 1988. A strong correlation between glomerular filtration rate and surface in diabetic nephropathy. Diabetologia, 31: 265-270.
28. Raskin, P., and Rosenstock, J. 1987. Aldose reductase inhibitors and diabetes complications. Am. J. Med. 83: 298.
29. Rocco, M.V., Chen, Y., Goldfarb, S., and Ziyadeh, F.N. 1992. Elevated glucose stimulates TGF-β gene expression and bioactivity in proximal tubule. Kidney Int. 41: 107-114.
30. Ruderman, N.B., Williamson, J.R., and Brownlee, M. 1992. Glucose and diabetic vascular disease. FASEB J. 6: 2905-2914.
31. Seyer-Hansen, K., Kansen, J., and Gunderson, H.J.G. 1980. Renal hypertrophy in experimental diabetes. A morphometric study. Diabetologia, 18: 501-505.
32. Tilton, R.G., Chang, K., Pugliese, G., Eades, D.M., Province, M.A., Sherman, W.R., Kilo, C., and Williamson, J.R. 1989. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors. Diabetes, 38: 1258-1270.
33. +. Kidney Int. 41: 778-788.
34. Vlassara, H., Brownlee, M., Monogue, K., Dinarello, C.A., and Pasagian, A. 1988. Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodelling. Science (Washington, D.C.), 240: 1546-1548.
35. Weibel, E.R. 1979. Practical methods for biological morphometry. In Stereological methods. Vol. 1. Academic Press, New York.
36. Whiteside, C.I., and Thompson, J.C. 1992. Upregulation of D-myoinositol transport in diabetic rat glomerular cells. Am. J. Physiol. 262: E301-E306.
37. Wolf, G., Sharma, K., Chen, Y., Ericksen, M., and Ziyadeh, F.N. 1992. High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β. Kidney Int. 42: 647-656.
38. Zatz, R., Dünn, B.R., Meyer, T.W., Anderson, S., Rennke, H.G., and Brenner, B.M. 1986. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J. Clin. Invest. 77: 1925-1930.